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ABSTRACT
Diagnosis of breast carcinomas has so far been limited to the
morphological interpretation of epithelial cells and the assess-
ment of epithelial tissue architecture. Consequently, most of
the automated systems have focused on characterizing the ep-
ithelial regions of the breast to detect cancer. In this paper, we
propose a system for classification of hematoxylin and eosin
(H&E) stained breast specimens based on convolutional neu-
ral networks that primarily targets the assessment of tumor-
associated stroma to diagnose breast cancer patients. We eval-
uate the performance of our proposed system using a large
cohort containing 646 breast tissue biopsies. Our evaluations
show that the proposed system achieves an area under ROC
of 0.92, demonstrating the discriminative power of previously
neglected tumor associated stroma as a diagnostic biomarker.
Index Terms— Digital pathology, Convolutional Neural
Networks, Breast Cancer, Tumor Associated Stroma
1. INTRODUCTION
Definitive diagnosis and interpretation of breast tissue spec-
imens have so far been based on morphological assessment
of epithelial cells. Pathologists traditionally perform a semi-
quantitative microscopic assessment of the morphological
features of the breast such as tubule formation, epithelial
nuclear atypia, and epithelial mitotic activity to detect and
characterize breast cancer [1]. While this assessment has
been useful for disease management of cancer patients, the
emergence of digital pathology encompassing computerized
and computer-aided diagnostics can lead to discovery of valu-
able prognostic information that provide new insights into the
biological factors contributing to breast cancer progression.
In [2], Beck et al. generated new insights into the importance
of stromal morphological characteristics as an important
prognostic factor in breast cancer that have been previously
ignored in the analysis of histopathology images. In addi-
tion, several studies have shown that higher stromal density
and extent of fibrosis is correlated with increased mammog-
raphy breast density [3] which confers a 4- to 6-fold risk
for breast cancer. These results concord with recent studies
which revealed that instead of cancer cells, the surrounding
tumor stromal cells known as cancer-associated fibroblasts
contribute to cancer progression [4, 5].
However, most of the existing algorithms for breast can-
cer detection and classification in histology images [6, 7, 8, 9]
involve assessment of the morphology and arrangement of ep-
ithelial primitives (e.g. nuclei, ducts). Several studies devel-
oped automated classification systems based on an initial seg-
mentation of nuclei and extraction of features to describe the
morphology of nuclei or their spatial arrangement [6, 7]. Naik
et al. [8] developed a method for automated detection and
segmentation of nuclear and glandular structures for classifi-
cation of breast cancer histopathology images. While all of
the previously mentioned algorithms were designed to clas-
sify manually selected regions of interest (mostly selected by
expert pathologists), in [9], we proposed an algorithm for au-
tomatic detection of ductal carcinoma in situ (DCIS) that op-
erates at the whole slide level and distinguishes DCIS from a
large set of benign disease conditions.
Unlike the existing work which focused on analysis of
epithelial tissue to detect and characterize breast cancer, we
sought to develop a novel data-driven system that primar-
ily analyzes stromal morphologic features to discriminate be-
tween breast cancer patients and patients with benign breast
disease. A crucial step in the development of the existing
algorithms has been the design of relevant hand-crafted fea-
tures. This step is intrinsically intractable for assessing the
morphology of tumor stroma in our work. The main rea-
son is that there is no precise definition of the morphologi-
cal properties of cancer-associated stroma among the pathol-
ogists. Moreover, the origin of tumor associated-stromal fi-
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broblasts is not entirely understood [4]. This motivates the
use of machine learning algorithms that can create their own
representations for the classification task. Within the field of
machine learning, a class of algorithms called deep learning
has been very successful in tasks such as image or speech
recognition. Deep learning exploits the idea of hierarchical
representation learning directly from input data to discover
statistical variations in the data. The most successful type
of deep learning models for image analysis are convolutional
neural networks (CNN). CNNs have also been used to detect
cancer areas in breast tissue specimen [10].
In this paper, we present a new automated system for
analyzing H&E stained breast specimen whole-slide-images
(WSI) based on CNNs. Our proposed system distinguishes
breast cancer from normal breast tissue based on stromal
characteristics of the tissue.
2. METHOD
Our proposed model for WSI classification of a breast biopsy
specimen consists of several steps. As a pre-processing step,
we used a pre-trained network for background/tissue classi-
fication. Subsequently, we trained two CNNs. The first one
classifies the WSI into epithelium, stroma, and fat. The sec-
ond operates on the stromal areas resulted from the classifica-
tion output of the first CNN, to classify the stromal regions as
normal stroma or cancer-associated stroma. Two sets of fea-
tures were extracted from the output of the two CNNs. The
first set of features, extracted from the first CNN, character-
izes the global tissue amount per class and spatial arrange-
ment of epithelial regions in the WSI. The second set was
extracted from the output of the second CNN to character-
ize several global features related to regions classified as tu-
mor associated stroma. Finally, a random forest classifier was
trained using these features to classify the WSI into cancer or
non-cancer.
2.1. Breast tissue component classification
Inspired by the success of VGG-net [11] which was ranked
at the top of ILSVRC 2014 challenge, we trained a VGG-
like convolutional neural network with 11 layers. VGG-net
uses 3 × 3 filters throughout the convolutional layers of the
network. Each convolutional layer was followed by a ReLU
activation function. We used 2× 2 max-pooling operation af-
ter the convolutional layers: 2, 4, 6, and 9. We started with
12 filters, and doubled the number of filters after each max-
pooling operation. The densely connected hidden layers have
2048, and 1024 units. To train the network, we replaced the
two fully connected layers of our network with 1 × 1 convo-
lutions. This is because fully-connected layers require fixed-
sized vectors, while convolutional layers accept arbitrary in-
put size; hence, replacing them would allow us to adopt the
deep network for images of arbitrary sizes. Hereafter, we de-
note this model as CNN I.
2.2. Classification of stromal regions into normal or
tumor-associated stroma
For the second classification task we used the standard 16-
layer VGG-net [11] which we refer to as CNN II. Similar
to CNN I, we turned this network into an fully convolutional
network to allow classification of arbitrary size inputs at test
time.
2.3. Classification framework and model parameters
The CNN training procedure for the two networks involves
optimizing the multinomial logistic regression objective (soft-
max) using stochastic gradient descent with Nesterov mo-
mentum [12]. The input to both networks is a 224×224 RGB
patch image sampled at the highest magnification. The batch
size was set to 128 and 22 for the CNN I and II, momentum
to 0.9. We used L2-regularization (λCNN−I = 0.003 and
λCNN−II = 0.0001) and dropout regularization with ratio
0.5 [13] (only applied to the last two layers of the network
with 1 × 1 convolutions). We used an adaptive learning rate
scheme. The learning rate was initially set to 0.01 and then
decreased by a factor of 5 if no increase in performance was
observed on the evaluation set, over a predefined number of
epochs which we refer to as epoch patience (Ep). The initial
value of Ep was set to 10. We increased this value by 20%
after each drop incidence in the learning rate. This prevented
the network from dropping the learning rate too fast at lower
learning rates. The weights of our networks were initialized
using the strategy by He et al. [14].
To augment the training set, patches were randomly ro-
tated and flipped. We additionally performed color augmen-
tations, by randomly jittering the hue and saturation of pixels
in the HSV color space. To generate the data for each mini-
batch, we randomly sampled patches from previously anno-
tated regions for each class with uniform probabilities.
The data for training our CNN II exhibits high class imbal-
ance in its distribution (there exists considerably more normal
stroma than cancer associated stroma). Although we tried to
increase the capacity of the network in learning discriminative
features to distinguish the minority class by uniformly sam-
pling the data for each mini-batch, we may fall into the risk
of training a very sensitive mode. Because the class distribu-
tion in each mini-batch does not represent the actual skewed
distribution of the data, a small number of false positives in
each mini-batch may translate to vast regions of false posi-
tives in the actual WSI. To ameliorate this effect, besides uni-
form sampling in each mini-batch, we gradually increased the
missclassification loss for the normal class. The loss weight
factor for the negative samples was initially set to 1, and mul-
tiplied by 1.0034 after each epoch (the weight factor becomes
2 by epoch 200). This ensured that the network learns dis-
criminative features from the beginning of the training pro-
cess and gradually learns the class distribution of the data as
well.
2.4. Feature extraction and WSI classification
CNN I was applied to the WSI in a sliding window approach
to generate a WSI map with three possible labels: epithelium,
stroma, and fat. CNN II was used to generate WSI likeli-
hood maps representing each pixel’s probability of belonging
to the tumor associated stroma class. Details of the features
extracted from the output of the CNN I model are presented
in Table 1. These features include: global tissue amount for
each class, morphological features of the epithelial areas, and
features extracted from Delaunay Triangulation [15] (built on
centroid of epithelial regions) and area-Voronoi diagrams [15]
(generated using the epithelial region areas). We extracted
similar features from the thresholded likelihood maps gener-
ated by CNN II (T = 0.9) for the connected components la-
beled as tumor associated stroma.
The resulting feature vector contained 71 features. These
features were used to train a random forest classifier with
100 random decision trees. All the parameters including the
threshold applied to likelihood maps generated by CNN II
were tuned using the combination of training and validation
sets with cross-validation.
Feature category Feature list
Global tissue amount Total area of epithelium, stroma, and fat and
the normalized areas of each tissue class by
the total tissue amount.
Morphology ∗Statistics of the area and eccentricity of ep-
ithelial regions
Delaunay Triangulation ∗Statistics of the number of neighbors for
each node and the distances of each node
with respect to others
Area-Voronoi diagram ∗Statistics of the areas of the Voronoi cells,
and the area ratio between the actual epithe-
lial region and its Voronoi zone of influence
(ZOI) [16].
Table 1. Features extracted from the classification results of
CNN I. ∗The statistics we computed are: mean, standard de-
viation, median, and inter-quartile range.
3. EXPERIMENTS
3.1. Dataset description
A total of 646 H&E stained breast tissue sections obtained
from 444 women referred for diagnostic image-guided breast
biopsies (including needle core biopsy and vacuum-assisted
biopsy) following an abnormal mammogram that were en-
rolled in the cross-sectional Breast Radiology Evaluation and
Study of Tissues (BREAST) Stamp Project [17] (2007-2010)
were included in this analysis. The tissue sections were dig-
itized using Aperio ScanScope CS scanner and Hamamuatsu
scanner at 20X magnification, and images have square pixels
of size 0.455× 0.455µm2.
Two trained students annotated a set of epithelial, stro-
mal, and fat regions in 100 WSIs to be used for training and
validation of CNN I. For the second network we used all the
Fig. 1. Sample classification result by CNN I (middle image) and CNN
II (bottom image) for a WSI containing breast cancer. In the middle image,
green, orange and red represent fat, stroma, and epithelium, respectively. The
bottom image shows the likelihood map representing tumor-stroma probabil-
ity overlaid on the original image (green represents low probability and red
represents high probability of belonging to tumor-associated stroma class).
previously annotated stromal regions in normal slides as neg-
ative samples. Samples for the tumor associated stroma class
were generated under the supervision of a pathologist by an-
notating stromal regions in the vicinity of epithelial cancer
regions.
3.2. Experimental design
The dataset was divided into non-overlapping training (270
WSIs with 223 benign disease and 47 invasive cancer), vali-
dation (80 WSIs with 65 benign disease and 15 invasive can-
cer), and testing (296 WSIs with 251 benign disease and 45
invasive cancer) sets. The training and validation sets were
used to find the best hyper-parameters for CNN I and II. The
independent test set was used to evaluate the performance of
the entire system. For training of both CNN I and II, we per-
formed two steps of hard negative mining (generating new
negative samples from the false positives of the model and
retraining).
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Fig. 2. The ROC curve of the proposed system. Confidence interval is only
shown for the system using both feature sets from CNN I and II.
The final performance of our system was evaluated us-
ing receiver-operating characteristic (ROC) analysis on the
likelihoods generated by the random forest classifier. Con-
fidence intervals (CI) were generated using patient-stratified
bootstrapping with 1000 intervals.
4. RESULTS AND DISCUSSION
CNN I achieved a pixel-level accuracy of 95.5% for classifica-
tion of tissue into epithelium, stroma, and fat. Fig. 1 shows an
example of the result produced by this model on a WSI. CNN
II achieved a pixel-level binary accuracy of 92.0% for classi-
fying stroma into normal stroma or tumor-associated stroma.
Fig. 1 also shows the results of classification for a slide con-
taining cancer.
The ROC curve for the final performance of the system
is shown in Fig. 2. The system achieved an AUC of 0.921
(95% CI 0.862-0.967) at the WSI level for distinguishing can-
cer from benign breast disease based on combination of both
feature sets. The AUC of the system when only considering
features from CNN I and CNN II independently was 0.882
and 0.904, respectively. The results demonstrate that breast
cancer can be accurately diagnosed based on the analysis of
stromal features alone, suggesting the centrality of alterations
to the breast stroma in the process of breast carcinogenesis.
5. CONCLUSION
In this paper we proposed a system for classification of WSIs
of breast tissue biopsies. While most previous work has fo-
cused on identification of nuclei or glands to characterize
abnormal texture patterns in the epithelial cancer regions,
we proposed the first system developed based on deep learn-
ing techniques to assess the stromal properties of the tissue
and investigate the discriminatory power of tumor associated
stroma as a diagnostic bio-marker for detecting cancer. These
results show that by using deep learning-based techniques, a
large amount of information required to discriminate breast
cancer from benign breast disease can be obtained from stro-
mal tissue alone. In the future, we will assess the role of
tumor associated stroma as a bio-marker to predict breast
cancer recurrence and as a predictor of breast cancer devel-
opment among women diagnosed with benign breast disease.
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